Completed PHASE3 INTERVENTIONAL 1-arm NCT00723047

Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial (Fibrin glue)

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Interventions Fibrin glue injection in fistula

Updated 7 times since 2017 Last updated: Sep 2, 2011 Started: Nov 30, 2003 Primary completion: Jun 30, 2006 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00723047, this PHASE3 trial focuses on Crohn's Disease and remains completed. Sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, it has been updated 7 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Nycomed
Société Nationale Française de Gastroentérologie

Data source: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Clichy, France , Colombes, France , Lille, France , Liège, Belgium , Marseille, France , Nice, France , Paris, France , Pierre-Bénite, France , Rennes, France , Rouen, France and 1 more location